|
1
|
Block TM, Mehta AS, Fimmel CJ and Jordan
R: Molecular viral oncology of hepatocellular carcinoma. Oncogene.
22:5093–5107. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thomas MB and Zhu AX: Hepatocellular
carcinoma: the need for progress. J Clin Oncol. 23:2892–2899. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frenette C and Gish RG: Hepatocellular
carcinoma: molecular and genomic guideline for the clinician. Clin
Liver Dis. 15:307–321. vii–x. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baeuerle PA and Baltimore D: NF-kappa B:
ten years after. Cell. 87:13–20. 1996.PubMed/NCBI
|
|
6
|
Siebenlist U, Franzoso G and Brown K:
Structure, regulation and function of NF-kappa B. Annu Rev Cell
Biol. 10:405–455. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pikarsky E, Porat RM, Stein I, Abramovitch
R, Amit S, Kasem S, et al: NF-kappaB functions as a tumour promoter
in inflammation-associated cancer. Nature. 431:461–466. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chan CF, Yau TO, Jin DY, Wong CM, Fan ST
and Ng IO: Evaluation of nuclear factor-kappaB, urokinase-type
plasminogen activator, and HBx and their clinicopathological
significance in hepatocellular carcinoma. Clin Cancer Res.
10:4140–4149. 2004. View Article : Google Scholar
|
|
9
|
Karin M and Lin A: NF-kappaB at the
crossroads of life and death. Nat Immunol. 3:221–227. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tak PP and Firestein GS: NF-kappaB: a key
role in inflammatory diseases. J Clin Invest. 107:7–11. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aita VM, Liang XH, Murty VV, Pincus DL, Yu
W, Cayanis E, et al: Cloning and genomic organization of beclin 1,
a candidate tumor suppressor gene on chromosome 17q21. Genomics.
59:59–65. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Friedman LS, Ostermeyer EA, Lynch ED,
Szabo CI, Anderson LA, Dowd P, et al: The search for BRCA1. Cancer
Res. 54:6374–6382. 1994.PubMed/NCBI
|
|
13
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh
H, Troxel A, et al: Promotion of tumorigenesis by heterozygous
disruption of the beclin 1 autophagy gene. J Clin Invest.
112:1809–1820. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edinger AL and Thompson CB: Defective
autophagy leads to cancer. Cancer Cell. 4:422–424. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang XH, Yu J, Brown K and Levine B:
Beclin 1 contains a leucine-rich nuclear export signal that is
required for its autophagy and tumor suppressor function. Cancer
Res. 61:3443–3449. 2001.PubMed/NCBI
|
|
18
|
Liang XH, Kleeman LK, Jiang HH, Gordon G,
Goldman JE, Berry G, et al: Protection against fatal Sindbis virus
encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol.
72:8586–8596. 1998.PubMed/NCBI
|
|
19
|
Qian YW, Wang YC, Hollingsworth RE Jr,
Jones D, Ling N and Lee EY: A retinoblastoma-binding protein
related to a negative regulator of Ras in yeast. Nature.
364:648–652. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li P, Du Q, Cao Z, Guo Z, Evankovich J,
Yan W, et al: Interferon-γ induces autophagy with growth inhibition
and cell death in human hepatocellular carcinoma (HCC) cells
through interferon-regulatory factor-1 (IRF-1). Cancer Lett.
314:213–222. 2012.
|
|
21
|
Alison MR, Nicholson LJ and Lin WR:
Chronic inflammation and hepatocellular carcinoma. Recent Results
Cancer Res. 185:135–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alva AS, Gultekin SH and Baehrecke EH:
Autophagy in human tumors: cell survival or death? Cell Death
Differ. 11:1046–1048. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baehrecke EH: Autophagy: dual roles in
life and death? Nat Rev Mol Cell Biol. 6:505–510. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kroemer G and Jäättelä M: Lysosomes and
autophagy in cell death control. Nat Rev Cancer. 5:886–897. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bours V, Dejardin E, Goujon-Letawe F,
Merville MP and Castronovo V: The NF-kappa B transcription factor
and cancer: high expression of NF-kappa B- and I kappa B-related
proteins in tumor cell lines. Biochem Pharmacol. 47:145–149. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jäättelä M: Multiple cell death pathways
as regulators of tumour initiation and progression. Oncogene.
23:2746–2756. 2004.PubMed/NCBI
|
